ACCD Accolade Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACCD

Price (delayed)

$9.265

Market cap

$717.18M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.61

Enterprise value

$728.86M

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade helps millions of people and their employers navigate the complexities of the ...

Highlights
The EPS has soared by 76% YoY and by 15% from the previous quarter
The company's net income has surged by 74% YoY and by 13% QoQ
Accolade's quick ratio has decreased by 26% YoY and by 24% from the previous quarter
The company's equity fell by 11% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.accolade.com
Peers: PRVA

Key stats

What are the main financial stats of ACCD
Market
Shares outstanding
77.41M
Market cap
$717.18M
Enterprise value
$728.86M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.62
Price to sales (P/S)
1.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.88
Earnings
Revenue
$388.49M
EBIT
-$127.36M
EBITDA
-$81.87M
Free cash flow
-$37.47M
Per share
EPS
-$1.61
Free cash flow per share
-$0.49
Book value per share
$5.7
Revenue per share
$5.1
TBVPS
$4.37
Balance sheet
Total assets
$785.47M
Total liabilities
$350.75M
Debt
$241.7M
Equity
$434.72M
Working capital
$156.42M
Liquidity
Debt to equity
0.56
Current ratio
2.35
Quick ratio
2.21
Net debt/EBITDA
-0.14
Margins
EBITDA margin
-21.1%
Gross margin
44.6%
Net margin
-31.6%
Operating margin
-35.5%
Efficiency
Return on assets
-14.4%
Return on equity
-27.3%
Return on invested capital
-44.8%
Return on capital employed
-19%
Return on sales
-32.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ACCD stock price

How has the Accolade stock price performed over time
Intraday
-0.91%
1 week
6.49%
1 month
-2.37%
1 year
-41.91%
YTD
-22.86%
QTD
-11.59%

Financial performance

How have Accolade's revenue and profit performed over time
Revenue
$388.49M
Gross profit
$173.4M
Operating income
-$137.76M
Net income
-$122.73M
Gross margin
44.6%
Net margin
-31.6%
The net margin has surged by 76% year-on-year and by 15% since the previous quarter
The company's net income has surged by 74% YoY and by 13% QoQ
The company's operating margin has surged by 73% YoY and by 8% QoQ
The operating income has soared by 71% YoY and by 6% QoQ

Growth

What is Accolade's growth rate over time

Valuation

What is Accolade stock price valuation
P/E
N/A
P/B
1.62
P/S
1.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.88
The EPS has soared by 76% YoY and by 15% from the previous quarter
The stock's price to book (P/B) is 14% less than its last 4 quarters average of 1.9
The company's equity fell by 11% YoY
ACCD's P/S is 17% lower than its last 4 quarters average of 2.2
The revenue is up by 9% year-on-year and by 2.2% since the previous quarter

Efficiency

How efficient is Accolade business performance
The ROS has soared by 75% YoY and by 14% from the previous quarter
The company's return on invested capital has surged by 70% YoY and by 7% QoQ
ACCD's return on assets has surged by 68% year-on-year and by 10% since the previous quarter
Accolade's ROE has soared by 65% YoY and by 11% from the previous quarter

Dividends

What is ACCD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACCD.

Financial health

How did Accolade financials performed over time
The total assets is 124% more than the total liabilities
Accolade's quick ratio has decreased by 26% YoY and by 24% from the previous quarter
The company's current ratio fell by 25% YoY and by 24% QoQ
The debt is 44% smaller than the equity
The debt has declined by 24% year-on-year and by 23% since the previous quarter
ACCD's debt to equity is down by 22% QoQ and by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.